Australian trial defines ideal prostate therapy
![Man in doctor's room](https://www.ausdoc.com.au/wp-content/uploads/2022/08/man-prostate-istock-968086632-1.jpg)
Australian researchers believe they’ve hit on the optimum duration of hormone-suppression therapy for men with aggressive, localised prostate cancers after a 10-year trial.
The findings from the RADAR study — which followed more than 1000 Australian men with advanced prostate cancer — show that 18 months of androgen suppression, coupled with moderate radiation dose escalation, is both tolerable and effective.